GAMCO Investors’s Cardinal Health CAH Stock Holding History

GAMCO Investors’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-6,000	Closed	-$453K	–	865
2023 Q1	$453K	Hold	6,000	–	–	﹤0.01%	701
2022 Q4	$461K	Buy	+6,000	New	+$456K	0.01%	704

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

GAMCO Investors's CAH Position: Q2 2023 in Review

GAMCO Investors sold out of Cardinal Health (CAH) in Q2 2023, closing a stake of 6,000 shares — an estimated $453K sold.

GAMCO Investors first reported a position in CAH in Q4 2022 and held it in 2 quarters. The position peaked at $461K in Q4 2022. 948 funds tracked by Wall St. Rank hold CAH as of Q2 2023.

GAMCO Investors reported no remaining Cardinal Health position as of Q2 2023 after selling out during the quarter.
GAMCO Investors sold 6,000 Cardinal Health shares in Q2 2023, an estimated $453K.
GAMCO Investors first reported a position in Cardinal Health in Q4 2022 and held it in 2 quarters.
GAMCO Investors's Cardinal Health position peaked at $461K in Q4 2022.
948 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2023.

Based on GAMCO Investors's 13F filing for Q2 2023, filed 10 Aug 2023.